SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical Trials
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Palevsky, P. M
Right arrow Articles by Smith, M. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palevsky, P. M
Right arrow Articles by Smith, M. W
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Design of the VA/NIH Acute Renal Failure Trial Network (ATN) study: intensive versus conventional renal support in acute renal failure

Paul M Palevsky

Renal Section, VA Pittsburgh Healthcare System and Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Room 7E123 (111F-U), VA Pittsburgh Healthcare System, University Drive Division, Pittsburgh, PA 15240, USA palevsky{at}pitt.edu

Theresa O'Connor

Jane Hongyuan Zhang

Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, USA

Robert A Star

National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

Mark W Smith

Health Economics Resource Center, VA Palo Alto Health Care System, Menlo Park, CA, USA

The optimal management of renal replacement therapy (RRT) in acute renal failure (ARF) is uncertain. The VA/NIH Acute Renal Failure Trail Network Study (ATN Study) tests the hypothesis that a strategy of intensive RRT will decrease 60-day all-cause mortality in critically ill patients with ARF. Dose separation between the two treatment arms is achieved by increasing the frequency of intermittent hemodialysis (IHD) and sustained low efficiency dialysis (SLED) treatments from three times per week to six times per week, and by increasing continuous venovenous hemodiafiltration (CVVHDF) effluent volume from 20 mL/kg/hr to 35 mL/kg/hr. In both treatment arms, subjects convert between IHD and CVVHDF or SLED as hemodynamic status changes over time. This strategy attempts to replicate the conversion between modalities of RRT that occurs in clinical practice. However, in order to implement this strategy, flexible criteria needed to be developed to provide a balance between the need for uniformity of treatment between groups and practitioner discretion regarding modality of RRT to maintain patient safety. In order to address safety and ethical issues similar to those raised by the Office of Human Research Protections in its review of the ARDS Network studies, a survey of practitioner practices was performed and observational data on the management of RRT in comparable critically ill patients with ARF managed outside of the research context is being collected prospectively. These data will help inform the study's DSMB and site IRB's of the relationship between the study's treatment arms and concurrent clinical practice.

Clinical Trials, Vol. 2, No. 5, 423-435 (2005)
DOI: 10.1191/1740774505cn116oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin TrialsHome page
J.-J. Pan, M. Nahm, P. Wakim, C. Cushing, L. Poole, B. Tai, and C. F Pieper
A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network
Clinical Trials, February 1, 2009; 6(1): 67 - 75.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. A. Desai, J. Baras, B. B. Berk, A. Nakajima, A. M. Garber, D. Owens, and G. M. Chertow
Management of Acute Kidney Injury in the Intensive Care Unit: A Cost-effectiveness Analysis of Daily vs Alternate-Day Hemodialysis
Arch Intern Med, September 8, 2008; 168(16): 1761 - 1767.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The VA/NIH Acute Renal Failure Trial Network
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
N. Engl. J. Med., July 3, 2008; 359(1): 7 - 20.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. T. Crowley, G. M. Chertow, J. Vitale, T. O'Connor, J. Zhang, R. M.H. Schein, D. Choudhury, K. Finkel, A. Vijayan, E. Paganini, et al.
Lessons for Successful Study Enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 955 - 961.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. L. Mehta and J. Bouchard
Dialysis Dosage in Acute Kidney Injury: Still a Conundrum?
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1046 - 1048.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. M. Chertow and S. S. Waikar
Toward the Promise of Renal Replacement Therapy
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 839 - 840.
[Full Text] [PDF]


Home page
CJASNHome page
J. L. Koyner and P. T. Murray
Mechanical Ventilation and Lung-Kidney Interactions
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 562 - 570.
[Full Text] [PDF]


Home page
JAMAHome page
N. Pannu, S. Klarenbach, N. Wiebe, B. Manns, M. Tonelli, and for the Alberta Kidney Disease Network
Renal Replacement Therapy in Patients With Acute Renal Failure: A Systematic Review
JAMA, February 20, 2008; 299(7): 793 - 805.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. W. Meyer and T. H. Hostetter
Uremia
N. Engl. J. Med., September 27, 2007; 357(13): 1316 - 1325.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. W. Teo, S. Demirjian, K. H. Meyer, E. Wright, and E. P. Paganini
Machine-generated bicarbonate dialysate for continuous therapy: a prospective, observational cohort study
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2304 - 2315.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Overberger, M. Pesacreta, P. M. Palevsky, and for the VA/NIH Acute Renal Failure Trial Network
Management of Renal Replacement Therapy in Acute Kidney Injury: A Survey of Practitioner Prescribing Practices
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 623 - 630.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. L. Mehta
Comparing Dialysis Modalities for Critically Ill Patients: Are We Barking up the Wrong Tree?
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 413 - 414.
[Full Text] [PDF]


Home page
Crit Care NurseHome page
S. Dirkes and K. Hodge
Continuous Renal Replacement Therapy in the Adult Intensive Care Unit: History and Current Trends
Crit. Care Nurse, April 1, 2007; 27(2): 61 - 80.
[Full Text] [PDF]


Home page
CJASNHome page
S. S. Waikar and J. V. Bonventre
Can We Rely on Blood Urea Nitrogen as a Biomarker to Determine When to Initiate Dialysis?
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 903 - 904.
[Full Text] [PDF]


Home page
CJASNHome page
K. D. Liu, M. A. Matthay, and G. M. Chertow
Evolving Practices in Critical Care and Potential Implications for Management of Acute Kidney Injury
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 869 - 873.
[Full Text] [PDF]



Advertisement